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ABSTRACT
OBJECTIVE: This study aims to examine how internalized stigma differs in opioid use disorder
(OUD) based on sociodemographic and clinical variables, and to what extent internalized
stigma is related to treatment motivation, perceived social support, depression, and anxiety
levels.
METHODS: One hundred forty-five individuals with OUD included. Sociodemographic and
clinical data form, the Internalized Stigma of Mental Illness Scale (ISMI), Treatment Motivation
Questionnaire (TMQ), Multidimensional Scale of Perceived Social Support, the Beck
Depression Inventory, and the Beck Anxiety Inventory were utilized in the study to collect
data. Bivariate and partial correlation coefficients between variables were computed. ISMI
and TMQ scores were compared between patients with depressive symptoms and patients
without depressive symptoms by using t-test and Mann Whitney U test.
RESULTS: Internalized stigma was high among male patients with heroin use disorder. There
was a positive correlation between internalized stigma score and treatment motivation,
depression, and anxiety levels. On the other hand, there was a negative correlation between
internalized stigma score and multidimensional perceived social support.
CONCLUSION: Internalized stigma occupies an important place in the treatment of OUD, which
occurs with frequent relapses and which is hard to treat. Not only application for treatment but
also adherence to treatment and treatment motivation at maintenance phase bestow a
complicated relationship with depression and anxiety. In the struggle against internalized
stigma, it plays a vital role to mobilize people’s social support systems, to educate families on
the issue and to get in touch with support units exclusive to heroin users.
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Introduction
Stigma is a multidimensional construct with different
types including public, perceived, enacted, and interna-
lized stigma, which are described by different researches
[1]. Stigmatization is an assignment of negative percep-
tions to an individual because of perceived difference
from the population at large. Being amember of an ethni-
cal group, having adisability, and substanceuse are among
the common possible reasons of stigmatization [2].
Internalized stigma refers to an individual’s adop-
tion of negative stereotypes in the society, and as a
result, retreating themselves from the society due to
negative feelings, such as unworthiness and embarrass-
ment [3]. Although there are some studies in the litera-
ture suggesting that internalized stigma appears prior
to public stigma and most of the time internalized
stigma emerges independently from public stigma,
there are also studies which argue that public stigma
leads to internalized stigma [4].
Initial studies on stigma were carried out on public
stigma. Recently, in the fight against stigma, it has been
understood that internalized stigma is a more accessi-
ble field, which is easier to study. Therefore, measure-
ment tools are being developed and the target has
been shifted to this field of research [5,6].
Psychiatric patients are extremely sensitive to both
public stigma and internalized stigma and effects of stig-
matization on patients with various diagnoses have been
studied extensively. In a study on patients with schizo-
phrenia, both internalized stigma and insight to illness
were positively correlated with suicidality [7]. In other
studies, internalized stigma was found to be correlated
with severity of psychiatric symptoms while it reduced
with adherence to treatment and control of symptoms
[8–14]. In patients with depression, symptom severity
also correlated with internalized stigma [12,15–17].
According to those studies, it may be important to tackle
patient’s internalized stigma in order to handle
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treatment of psychiatric disorders because internalized
stigma impairs treatment compliance, insight, social
interaction, and life quality of patients.
Substance use disorder (SUD) is among the most
highly stigmatized psychiatric disorders. Indeed,
some researchers consider the categorization of alco-
hol–SUD as a mental illness to be a stigma itself [4].
Partly reflecting those concerns, in Diagnostic and Stat-
istical Manual of Mental Disorders (DSM-5) [18], the
term “addiction” was removed because it was believed
that it is a vogue term causing negative connotations in
individuals and society; instead, a new term “substance
use disorder” (which was envisaged to be a more neu-
tral term) was used.
Studies which tackle internalized stigma in SUD
from multiple aspects are quite limited. It has been
shown that treatment-seeking patients’ beliefs on mor-
ality and immorality are associated with more interna-
lized stigma and greater social distance [19]. There are
also some studies which indicate that healthcare pro-
fessionals consider OUD as a moral and behavioural
problem rather than as an illness [20,21]. Several
studies have identified internalized stigma as a signifi-
cant barrier for accessing healthcare and substance/
alcohol use treatment services [22].
Under the light of this literature, it is believed that
internalized stigma is of significant importance in man-
agement of OUD. In this study, we aimed at examining
internalized stigma in OUD from multiple angles. For
this purpose, we evaluated the relationship between
internalized stigma and treatment motivation in
individuals with OUD. Furthermore, we examined
internalized stigma’s relationship with social support,
depression, and anxiety symptoms.
Method
Sample of the study
The study sample consisted of 166 consecutive male
patients (aged 16-65) who received outpatient treat-
ment at the Ankara Numune Research and Training
Hospital’s Alcohol and Substance Addiction Treatment
and Research Center (ASATRC) Outpatient Clinic
between November 2014 and March 2015. were evalu-
ated for potential inclusion. The final sample of the
study consisted of 145 patients (Figure 1). The Ethical
Board of Ankara Numune Training and Research Hos-
pital approved the study with the number E14-296 on
17 September 2014.
Psychological scales
Sociodemographic and clinical data form
This form is composed of 15 questions aiming to ident-
ify sociodemographic and substance use character-
istics. This descriptive information form includes
questions regarding demographic features such as
age, gender, profession, occupation, education and
income levels, marital status, place of residence and
cohabitation, and questions regarding clinical variables
such as substance use duration, prior treatment/admis-
sion at ASATRC and previously received treatments.
The Internalized Stigma of Mental Illness Scale
The scale which was developed by Ritsher et al. is a 29-
item self-report questionnaire designed to measure
internalized stigma. The validity and reliability of the
Turkish version were tested and confirmed by Ersoy
[9]. The scale is composed of five subscales (Alienation,
Perceived Discrimination, Social Withdrawal, Stereo-
type Endorsement, and Stigma Resistance) and it
measures people’s subjective experiences of stigma.
Items of “Stigma Resistance” are reverse coded. The
total score of Internalized Stigma of Mental Illness
(ISMI) Scale (which is obtained by adding up points
of five subscales) ranges from 4 to 116. High scores
in ISMI Scale indicate that individual’s internalized
stigma is negatively more severe [9].
Treatment Motivation Questionnaire
Treatment Motivation Questionnaire (TMQ) is a 26-
item self-report questionnaire which measures the
reasons of each case for participating and pursuing an
alcohol/SUD treatment. Factorial analyses show that
the questionnaire has four identifiable factors called
internalized motivation, external motivation, interperso-
nal help-seeking, and confidence in treatment. The
reliability and validity of Turkish version of TMQ in
alcohol dependents were carried out by Evren et al. [23].
Multidimensional Scale of Perceived Social
Support
Multidimensional Scale of Perceived Social Support
(MSPSS) is a 12-item scale which measures the extent
to which individuals assess social support from three
sources. The scale is composed of four items in each
of the three groups, which are family, friends, and sig-
nificant others (prospective spouse, dated person, rela-
tive, neighbour, doctor, etc.).Figure 1. Patient flow chart; reasons for ineligibility.
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Beck Depression Inventory
Beck Depression Inventory (BDI) measures physical,
emotional, cognitive, and motivational symptoms
experienced in depression. It was developed by Beck
et al. in 1961 and validity and reliability studies regard-
ing its Turkish version were carried out by Tegin in 1980
and by Hisli in 1989. In this study, the cutoff was deter-
mined as 17, and it was reported that scores equal to or
above 17 in the BDI could differentiate, with 90% accu-
racy, the depression which requires therapy.
Beck Anxiety Inventory
Beck Anxiety Inventory (BAI) was developed by Beck
et al. in 1988 and its Turkish translation was offered
by Ulusoy et al. for use. It is a self-report scale which
is used to determine the frequency of anxiety symp-
toms experienced by individuals.
Statistical analysis
Shapiro–Wilk test was used as the normality test. Con-
tinuous variables were compared using Student t-test
and Mann–Whitney U test when the data are not nor-
mally distributed. Correlations between variables were
tested using Pearson or Spearman correlation coeffi-
cients. Partial correlation coefficient was calculated
while controlling depression on the relationship between
internalized stigma and treatment motivation. A p-value
<.05 was considered as significant. Statistical analyses
were performed with IBM SPSS ver.23.0.
Results
Sociodemographic and clinical characteristics
Tables 1 and 2 show the demographic and clinical
characteristics of the individuals with OUD. The
mean age of patients who participated in the study
was 23.7 ± 5.5 (Tables 1 and 2).
While 77 patients (53.1%) met only heroin use dis-
order diagnostic criteria within the last year, the
remaining 68 patients (46.9%) were using amphet-
amine, cocaine, cannabis, and synthetic cannabinoids
occasionally (not regularly) in addition to heroin.
It was found out that 97 of the patients (66.9%)
had previously applied to ASATRC for treatment,
and 37 of the patients had been admitted to ASATRC
as inpatients. Twenty-one patients had received inpati-
ent treatment once; 16 patients had received inpatient
treatment twice.
ISMI, TMS, MSPSS, BDI, and BAI scores of
patients
It was found that mean ISMI Scale score was 81.3 ±
15.3 (40–113), the mean score of Alienation subscale
was 18.1 ± 4.3 (6–36), the mean score of Stereotype
Endorsement subscale was 18.5 ± 4.6 (7–28), the
mean score of Perceived Discrimination subscale was
13.6 ± 3.8 (5–26), the mean score of Social Withdrawal
subscale was 16.84 ± 4.52 (6–24), and the mean score of
Stigma Resistance subscale was 14.41 ± 2.49 (7–20).
In terms of treatment motivation, the mean score of
TMQ was 72.6 ± 14.4 (24–96), the mean score of inter-
nalized motivation subscale was 36.9 ± 8.9 (0–44), the
mean score of external motivation was 8.2 ± 3.3 (0–
16), the mean score of interpersonal help-seeking sub-
scale was 14.5 ± 5.5 (0–24), and the mean score of
confidence in treatment subscale was 13.1 ± 4.1 (3–20).
It was detected that the mean score of MSPSS was
55.4 ± 16.8 (14–84), the mean score of family social
support subscale was 24.03 ± 5.19 (4–28), the mean
score of friends social support subscale was 15.9 ± 7.8
(4–28), and the mean score of significant others social
support subscale was 15.5 ± 8.6 (4–28).
It was observed that the mean score of BDI was 25.5 ±
12.9 (0–57), and themean score of BAIwas 29.8 ± 15.9 (0–
63).When depression symptomswere evaluated based on
cutoff 17, it was found out that 111 subjects showed
depression symptoms to the extent of requiring therapy.
Table 1. Demographic characteristics of heroin users.
Median (min–max)
Age 23 (16–57)
Years of education 9 (4–17)
Duration of substance use 2 (1–16)
N %
Marital status
Single 111 76.6
Married 30 20.7
Divorced 4 2.8
Place of residence
City 105 72.4
Town 37 25.5
Village 3 2.1
Monthly income
0–500 TL 68 46.9
500–1500 TL 61 42.1
1500– 16 11.0
Working status
Not working 68 46.9
Working 77 53.1
Duration of working
0–1 year 21 14.5
1–5 years 85 58.6
5– 39 26.9
Table 2. Clinical characteristics of heroin users.
n %
History of treatment in ASATRC
Yes 97 66.9
No 48 33.1
Hospitalized in ASATRC
Yes 37 25.5
No 108 74.5
Comorbid medical disease
Yes 0 0
No 145 100
Previously prescribed suboxone
Yes 63 43.4
No 82 56.6
Substance type
Heroin 77 53.1
Heroin and others 68 46.9
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The relationship between sociodemographic
and clinical data with internalized stigma scores
Our study revealed that internalized stigma is high
among male patients with OUD. It was found that
the overall score of stigma is higher in patients with
low income (81.4 ± 16.1, p = .144). It was shown that
overall stigma scores of patients who do not have any
employment history were higher compared to those
who have regular jobs (83.8 ± 13.9, p = .863); and the
stigma resistance of the former was low (13.9 ± 2.8,
p = .607). However, the differences between sociode-
mographic data and overall scale and subscale scores
for internalized stigma in mental illnesses were not
statistically significant. In terms of clinical variables,
it was found that overall scores of alienation were
significantly lower in patients who have not applied
to ASATRC before compared to those who have
applied.
The relationship between ISMI Scale and TMQ
scores
There was a positive relationship between Alienation
and overall score for TMQ, subscales of internalized
motivation, interpersonal help-seeking; between
Stereotype Endorsement and overall score for TMQ,
subscales of internalized motivation, external motiv-
ation, interpersonal help-seeking; between overall
score for TMQ and subscales of internalized motiv-
ation, external motivation, interpersonal help-seeking;
between social withdrawal and overall score for
TMQ, subscales of internalized motivation, external
motivation, interpersonal help-seeking; between
Stigma Resistance and subscale of confidence in treat-
ment; and between overall score for ISMI Scale and
overall score for TMQ, subscales of internalized
motivation, external motivation, interpersonal help-
seeking (Table 3).
Positive correlation was found between overall score
for internalized stigma scale in patients with depression
and overall score for TMQ (p = .001, r = 0.314). It was
observed that when depressive state was under control,
there was still a positive correlation between interna-
lized stigma and treatment motivation even though
power of the correlation was weak (p = .001, r = 0.267).
The relationship between ISMI Scale and MSPSS
scores
There was a weak significantly negative relationship
between overall score for MSPSS and subscales of social
support from friends, social support from significant
others; between Stereotype Endorsement and overall
score for MSPSS, subscales of social support from
friends; between Perceived Discrimination and overall
score for MSPSS, subscales of social support from
friends and social support from significant others;
between Social Withdrawal and overall score for
MSPSS, subscales of social support from friends and
social support from significant others; between Stigma
Resistance and overall score for MSPSS, subscale of
social support from significant others; and between
overall score for ISMI Scale and overall score for
MSPSS, subscales of social support from friends and
social support from significant others (Table 4).
The relationship between ISMI Scale and BDI
and BAI scores
There was a positive relationship between overall score
for ISMI Scale as well as its subscales and BDI and BAI
scores (Table 5).
Table 3. The relationship between ISMI Scale and TMQ scores.
Alienation Stereotype endorsement Perceived discrimination Social withdrawal Stigma resistance Total score
Internalized motivation r .219 .200 .224 .289 .116 .284
p .008 .016 .007 <.001 .165 .001
External motivation r .075 .311 .295 .296 −.012 .301
p .367 <.001 <.001 <.001 .888 <.001
Interpersonal help-seeking r .215 .228 .286 .309 .035 .303
p .009 .006 <.001 <.001 .678 <.001
Confidence in treatment r .051 −.100 −.153 −.106 .203 −.082
p .541 .229 .065 .203 .014 .328
Overall score r .231 .244 .280 .332 .139 .327
p .005 .003 .001 <.001 .095 <.001
Table 4. The relationship between ISMI Scale and MSPSS scores.
Alienation Stereotype endorsement Perceived discrimination Social withdrawal Stigma resistance Total score
Family r −.052 −.072 −.055 −.088 −.056 −.098
p .532 .391 .511 .293 .505 .240
Friends r −.277 −.263 −.244 −.249 −.140 −.331
p .001 .001 .003 .002 .094 <.001
Significant others r −.292 −.134 −.217 −.243 −.188 −.290
p <.001 .107 .009 .003 .023 <.001
Total score r −.298 −.226 −.262 −.275 −.178 −.342
p <.001 .006 .001 .001 .033 <.001
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Subjects were divided into two groups as those “who
have depression symptoms” and those “who do not
have depression symptoms” according to BDI 17
cutoff criterion, and scores for ISMI Scale for both
groups were presented in Table 6.
Discussion
The relationship between sociodemographic
and clinical characteristics and internalized
stigma
In our study, it was revealed that internalized stigma was
high amongmale patients with OUD. This finding is con-
sistent with previous studies in the literature [4]. However,
the number of related studies in this field is limited.
Although it may seem as a limitation to have only male
patients with OUD in the sample of the study, it is how-
ever a nice representation of the society because it is well
known that the majority of individuals with opioid use
disorder in the society are men. This situation can be
associated with the fact that men with OUD are perceived
to be more aggressive and dangerous compared to
women, thus experiencing more public stigma. There is
a strong need for studies which examines the role of
gender in internalized stigma in OUD.
It was also observed that income levels of patients
were low and less than half of them continue to
work; therefore, the overall stigma scores of patients
who had low income and who did not have any
employment history were found to be higher. This is
an indication of the fact that perception of stigma has
impacts on individual’s status in the society, individ-
ual’s social functioning, and eventually the income.
However, the relationship between these economic
and sociodemographic characteristics of patients and
internalized stigma was not found statistically signifi-
cant in this study. These results are consistent with
many studies in the literature [8,12,16,24].
Although not statistically significant, it was found
that alienation scores of patients who did not apply
to ASATRC before were significantly higher com-
pared to those who had ASATRC history. It is not
surprising to see that individuals with SUD who are
highly likely to alienate themselves from society are
less willing in terms of treatment and getting help
from ASATRC. On the other hand, it is suggested
that treatment process increases labelling and thus,
internalized stigma. One of the significant examples
which can be given for this suggestion is that metha-
done treatment (which is marketed with big hopes)
has not attracted the expected attention, and patients
with SUD who have this treatment usually keep their
treatment as a secret [25,26].
When six dimensions (concealability, disruptive-
ness, course, peril, aesthetics, and origin, which play
important roles in individual’s sensitivity to stigma)
are analysed, it is possible to mention that individuals
with SUD meet these criteria. Heroin use turns into
an addiction and a chronic process in a short time,
and its concealability gets even harder at the same
speed. The efforts of patients, who show decreasing
self-care, shrinking social environment, and withdra-
wal symptoms time to time, are most of the time
insufficient in concealing their OUD. Society per-
ceives such people as dangerous and unpredictable,
and puts the blame on their moral and personality
traits for their actions. All these increase public
stigma even more. People’s existence abilities at
social, occupational and economic levels, which are
considered to be the most effective factors in stigma,
are the ones which individuals with opioid use dis-
order frequently and rapidly lose [4].
In a study on patients with alcohol use disorder
and their relatives carried out by Arıkan et al. in
2004, it was shown that patients’ relatives considered
OUD more as a personality problem; both patients
and their relatives perceived substance use as a
moral weakness and personality shortcoming; how-
ever, it was concluded that the increase in the number
of inpatients decreased this perception [27].
The relationship between treatment motivation
and internalized stigma
It has been shown in many studies that internalized
stigma jeopardizes the adherence to the treatment
[28]. In our study, it is presupposed that treatment
motivation has an important role in adherence to the
Table 6. The relationship between ISMI Scale and depression
symptoms.
Who have
depression
symptoms
(n = 111)
Who do not have
depression
symptoms
(n = 34) P
Mean ± std dev. Mean ± std dev.
Alienation 18.92 ± 3.57 15.47 ± 5.44 .001
Stereotype endorsement 19.29 ± 3.78 15.79 ± 5.85 .001
Perceived discrimination 14.32 ± 3.34 11.41 ± 4.38 <.001
Social withdrawal 17.83 ± 3.75 14.06 ± 5.55 <.001
Stigma resistance 14.55 ± 2.47 13.97 ± 2.54 .152
Total score 84.59 ± 12.18 70.71 ± 19.39 <.001
Table 5. The relationship between ISMI Scale and BDI and BAI scores.
Alienation Stereotype endorsement Perceived discrimination Social withdrawal Stigma resistance Total score
Depression symptoms r .277 .291 .363 .410 .172 .412
p .001 <.001 <.001 <.001 .039 <.001
Anxiety symptoms r .218 .292 .381 .390 −.077 .370
p .008 <.001 <.001 <.001 .360 <.001
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treatment and the increase in stigma can hinder treat-
ment motivation. However, a positive relationship
between internalized stigma and treatment motivation
was not found in the current study. This finding which
may seem as a contradiction can be explained with
transtheoretical model of change which posits that
there are five stages of behavioural change in SUD,
namely precontemplation, contemplation, preparation,
action, and maintenance [29,30]. In a limited number
of studies carried out in this field, similar to our
findings, it has been established that individuals with
SUD are initially very eager and motivated for treat-
ment. However, it has been shown that their eagerness
and motivation decrease with the onset of treatment
process; the chances of their maintenance with the
treatment in long term and getting positive results
are quite low [31,32]. Most of the time, such people
get stuck in the preparation stage in which they think
that change would be useful for themselves and they
would try to change later on; therefore, most of the
time, action and maintenance stages do not follow
this stage [33]. In maintenance stage, being ready for
change becomes a more important concept than
being ready for the treatment. Our study involved
patients with heroin use disorder who applied to
ASATRC, or in other words, who were already in the
stages of preparation and action. Therefore, there was
a positive relationship between treatment motivation
levels and stigma levels. It is worth pursuing a further
study which examines to what extent these patients’
motivation levels change in their long-term follow-
ups, or in other words, in the maintenance stage, and
its relationship with stigma. As a matter of fact, some
studies show that there is a negative relationship
between change readiness and internalized stigma [34].
Furthermore, it has been found that social, psycho-
logical, and physical negative consequences of alco-
hol/substance use were associated with the
likelihood of behaviour change in OUD and motiv-
ation for change during treatment [33]. Even though
lack of motivation is considered to be a sign in
depressive disorder, in a limited number of studies,
it was shown that treatment motivation of patients
with depressive disorder was high compared to
those who did not have depressive disorder [35–37].
The reason for this could be that individuals start
to regard their OUD as the cause of the negative con-
sequences they experience, and for this reason their
motivation for treatment increases. In our study, it
was shown that social problems such as education,
low income level, unemployment, and psychological
problems such as depression, anxiety, and stigma
were high among patients; therefore, it could be
suggested that this could have caused high levels of
treatment motivation. It was observed in our study
that when depressive condition was under control,
there was a similar positive relationship between
internalized stigma and treatment motivation. This
suggests that internalized stigma increased treatment
motivation independently from depression status.
However, these patients’ treatments were interrupted
frequently and they continued to use substances
time to time; therefore, their motivation did not
remain consistent in a way to cause a significant
behavioural change.
In various studies, it has been shown that interna-
lized motivation is more effective on long-term change
than external motivation [33]. Even among those who
were legally forced to receive treatment, awareness of
the problems related to the substance use determined
high participation level into the treatment [33].
When internalized and external motivations exist
together, the success of treatment is much higher. For
individuals with SUD, external motivation could
emerge due to pressure from social circle, law force,
and public stigma. It can be thought that when such
individuals internalize public stigma, their internalized
motivation increases. For this reason, as stigma and
perception of stigma increase, levels of internalized
and external motivations could increase.
As observed in clinical practice, treatment motiv-
ation of individuals with OUD is greatly related to
their thinking that they could get rid of their OUD
painlessly and effortlessly by using painkillers, muscle
relaxants, and a combination of buprenorphine plus
naloxone. However, OUD treatment process is not
always as comfortable as patients expect. It is com-
monly observed in ASATRC that individuals with
OUD who are motivated for treatment and admis-
sion to the clinic in the beginning often demand dis-
charge or leave the clinic without permission shortly
after they have admitted to the clinic because of crav-
ing withdrawal symptoms and severe pain.
Social withdrawal observed in individuals with
OUD increases due to discrimination and stigma
they experience. Therefore, individuals may tend to
use substances due to the lack of relationship and com-
munication with other people even though they could
be in great need for it. On the other hand, their need
to establish relationships with the society still con-
tinues. This undesirable situation may in turn lead
them to treatment and increase their treatment motiv-
ation at initial stage.
The relationship between perceived social
support and internalized stigma
In our study, a negatively significant relationship was
found between internalized stigma and perceived social
support. This result is consistent with the study of Living-
ston and Boyd [8] on people living with mental illness in
which it was found that there was a negative relationship
between internalized stigma levels and self-esteem, self-
efficacy, quality of life, hope, and social support [8] as
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well as with a study carried out in Turkey in 2013 exam-
ining the relationship between internalized stigma in psy-
chiatric inpatients and perceived family support, which
showed a strong negative correlation between interna-
lized stigma levels and perceived family support.
Alcoholics Anonymous (AA) and Narcotics Anon-
ymous (NA) are of significant importance in terms of
social support systems for alcohol and substance users.
It has been shown that in a three-year longitudinal
study, alcohol users who continued to attend AA stayed
sober 35% more in a year than compared to those who
did not, and also decreased their drinking by 16% [38].
It is expected to see a decrease in internalized stigma
as the perceived social support increases in opioid
users. Therefore, it is vital to obtain the family support
for people with OUD and to include other social sup-
port systems, to decrease internalized stigma and to
increase adherence to the treatment.
The relationship between symptoms of
depression and anxiety and internalized stigma
In our study, it was observed that depression and anxiety
symptoms are high in patients with OUD and it was
established that they were positively associated with
internalized stigma. There are a limited number of
studies in literature which examine the relationship
between internalized stigma and anxiety levels. In
related studies which included patients diagnosed with
psychotic disorder, bipolar disorder, and depressive dis-
order, a positive relationship between anxiety level and
internalized stigma was found. It is possible to see that
people living with OUD are more prone to think that,
similar to the general belief of the society, the situation
they are facing results from their mistakes, and they
blame themselves for this. This way of thinking increases
the already experienced public and internalized stigma
even more. In addition, such people may turn the feeling
of hate resulting from stigma into depression symptoms
such as embarrassment, pessimism, and unworthiness,
and in this way they may, in a way, avoid the effects
of hate [39]. Therefore, as the feeling of stigma increases,
the symptoms of depression and anxiety increase, as
well. Consequently, our study conforms to the previous
studies in the literature [15,40–42].
Our study group consists of only male outpatients
because of its cross-sectional design and characteristics
of our patient population in Ankara Numune ASATRC
as a limitation. Study design with a larger participation
could enable one to explore gender differences and
differences between inpatients and outpatients.
Conclusion
There has not been a study in the literature examining
the relationship between internalized stigma and rel-
evant variables in patients with OUD in Turkish
society so far. This is the first study carried out on
this subject, in Turkey. Furthermore, we are of the
opinion that this study proves itself to be valuable in
terms of offering a different perspective for the
relationship between stigma and treatment motivation.
All the results show that internalized stigma occupies
an importantplace in the treatmentofOUD,whichoccurs
with frequent relapses andwhich is hard to treat. Not only
application for treatment but also adherence to treatment
and treatment motivation at maintenance phase bestow a
complicated relationship with depression and anxiety. In
the struggle against internalized stigma, it plays a vital
role tomobilize people’s social support systems, to educate
families on the issue and to get in touchwith support units
exclusive to individuals with OUD.
It seems possible to increase the success of OUD
treatment by understanding the nature of internalized
stigma and developing treatment strategies aiming at
reducing this perception. In this regard, more studies
need to be carried out in this field and a great deal of
effort should be put in adjusting stigma and perception
of stigma in an effective way at a practical level.
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